2nd International Pediatric
Cardio-Oncology Conference

November 8-9, 2024 || Cincinnati Ohio

2nd International Pediatric Cardio-Oncology Conference | November 8-9, 2024


Topics to be covered include: 

  • Emerging therapies in pediatric cardio-oncology, including ICI, targeted therapies, CAR T-cell

  • Approach to therapy in patients with cardiotoxicity

  • Cardiometabolic syndrome and cardiovascular risk factors in survivors of pediatric cancer

  • Cardio-protective strategies in cancer therapy

  • Surveillance for cardiotoxicity

  • Case presentations and patient discussion with experts in the field of cardio-oncology


 

2nd International Pediatric Cardio-Oncology Conference 

Preliminary Agenda
Times are not final and subject to change
 

PRECONFERENCE ACTIVITIES 

Thursday, November 8th, 2024

Hospital Tour | 3-4pm 

Welcome Reception hosted by The International Cardio-Oncology Society (Evening) 

Separate registration will be required | Exact time TBD 

Friday, November 8th, 2024 

Registration and breakfast available | 7-8am 

Welcome | 8-8:30am

Focus Block 1 | 8:30-9:45am | New Therapeutics in Oncology and Implications for Pediatric Cardio-Oncology 

Session Leaders: Rajaram Nagarajan, MD, MS – Texas Children’s; Eric Chow, MD, MPH – Seattle Children’s; and Louis S. Constine, MD – University of Rochester Medical Center 

Evolution of Systematic Therapy and Impact on Cardiotoxicity Hodgkin Lymphoma as a Paradigm  | 25-minute presentation | Kasey Leger, MD, MS – Seattle Children’s   

Redefining the Impact of Radiotherapy on the Heart | 25-minute presentation | James Bates, MD - Emory 

25-minute Combined Q&A 

 Break | 9:45-10am

Focus Block 2 | 10-11:30am | Surveillance, Managing Cardiovascular Risk Factors, and Cardiometabolic Risk in Cancer Survivors (+/- Exercise) 

Session Leaders: Julia Steinberger, MD – University of Minnesota; Daniel A. Mulrooney, MD – St. Jude Children’s Research Hospital; and Lois Travis, MD, ScD – Indiana University 

Surveillance and Managing CVD Risk Factors | Eric Chow, MD, MPH – Seattle Children’s | Julia Steinberger, MD – University of Minnesota | Suparna Clasen, MD – Indiana University School of Medicine   

Cardiometabolic Risk in Cancer Survivors: Exercise interventions | Live Demo | Kirsten Ness, PT, PhD – St. Jude Children’s Research Hospital | Jessica Scott, PhD – Memorial Sloan Kettering Cancer Center  

Lunch | 11:30-12:45pm

Focus Block 3 | 12:45-2pm | Clinical Cancer Survivorship Research: Learning Collaboratives, Lessons Learned, and Active Research Findings 

Session Leaders: Steven E. Lipshultz, MD – University at Buffalo, Lois B. Travis, MD, ScD – Indiana University, and Leontien Kremer, MD, PhD – Princess Maxima Center 

The Driving Force: Facilitating Research Teams | presentation | Lois B. Travis, MD, ScD – Indiana University  

The Dutch LATER and European Survivorship Research Overview | presentation | Leontien CM Kremer, MD, PhD – Princess Maxima Center 

 Survivorship Research Overview from the CCSS and the St. Jude Life Cohort Study | presentation | Greg Armstrong, MD, MSCE – St. Jude Children’s Research Hospital 

Implementation of Pediatric Cardio-Oncology Clinical Research to Improve Lifespan Quality of Life: Uses, Misuses, Abuses, and Disuses | presentation | Steven E. Lipshultz, MD – University at Buffalo  

Break | 2-2:15pm

Focus Block 4 | |2:15-4:15pm | Cardiomyopathy, Heart Failure, and Cardiac Transplant - Cardiac Therapies and Management in Pediatric Cardio-Oncology 

Session Leaders: Jeffrey A. Towbin, MD - Le Bonheur Children’s Hospital and Nathanya Baez-Hernandez, MD – UT Southwestern Medical Center 

Not so simple: Understanding the cardiomyopathy spectrum in cancer patients | Jeffrey A. Towbin, MD – Le Bonheur Children’s Hospital 

Cardiac Assessment in Cancer Patients | Luc Mertens, MD – The Hospital for Sick Children in Toronto

From Sub-Clinical to Advanced Cardiotoxicity: Cardiomyopathy Management in Pediatric Cancer Patients | Roundtable using case series | Jean Ballweg, MD – Helen DeVos Children’s Hospital | Hugo Martinez, MD –University of Tennessee Health Science Center | Jeffrey A. Towbin, MD – Le Bonheur Children’s Hospital | Sydney Elizer, MD – Phoenix Children’s Hospital   | Mathew Mosgrove, MD - UT Southwestern Medical Center 

 Exploring the Limits in the Management of Heart Failure in Pediatric Cancer Patients | David Sutcliffe, MD — Children’s Mercy Kansas City 

Break | 4:15-4:30pm

Advocacy Session | 4:30-5:30pm | Survivor Voices:  Living with Cardiac Late Effects and Unmet Needs 

Session Leaders: Marta Blanco – Sofia’s Hope and Jacob Adams, MD – University of Rochester  

Introduction | 5-minute intro | Marta Blanco – Sofia’s Hope and Jacob Adams, MD – University of Rochester 

 Survivor Stories | 10 -12 minutes talks each followed by 15-20 min Q&A | Peter Wolf | Ania Buchacz | Kerri Becktell, MD – Children’s Hospital of Wisconsin  

Abstract Oral Presentation | 5:30-6pm

Session Leaders: Steven E. Lipshultz, MD – University at Buffalo and Thomas D. Ryan, MD – Cincinnati Children’s  

Top 3 abstracts, 7 min presentation with 3 min questions 

Poster Session/Reception | 6-7pm 

Faculty Dinner | 7:30-9:30pm

Saturday, November 9, 2024

Breakfast available 7-8am

CO Academy | 7:15-7:45am

Session Leaders: Thomas D. Ryan, MD – Cincinnati Children’s Hospital Medical Center and Jonathan Bender, MD – Cincinnati Children’s Hospital Medical Center 

Optional learning sessions running concurrently: 

Path 1 – Oncology for the Cardiologist – Jonathan Bender, MD – Cincinnati Children’s Hospital Medical Center 

Path 2 – Cardiology for the Oncologist – Hugo Martinez, MD – University of Tennessee Health Science Center 

Keynote Session | 8-9am: Social Determinants of Outcomes in Cardio-Oncology 

Session Leaders: Thomas D. Ryan, MD – Cincinnati Children’s Hospital Medical Center and Greg Armstrong, MD, MSCE – St. Jude Children’s Research Hospital 

40 min talk with time for discussion | Daniel Addison, MD – Ohio State University   

Focus Block 5 | 9-10:30am | The Burden of Cancer Therapy on Childhood and Adolescent and Young Adult (AYA) Cancer Survivors, including Transitioning Care  

Session Leaders: Anecita Fadol, PhD, APRN – MD Anderson Cancer Center and Louis S. Constine, MD – University of Rochester Medical Center 

Unraveling the Complexities of the Genesis of Organ Toxicities from Cancer Therapy in Childhood Cancer Survivors | 15-minute presentation | Louis S. Constine, MD – University of Rochester Medical Center 

Surveillance of Childhood and AYA Cancer Survivors | 15-minute presentation | Matthew Ehrhardt, MD – St. Jude Children’s Research Hospital  

From Child-Centered Care to Adult-Oriented Care: Journey of Childhood and AYA Cancer Survivors | 15-minute presentation | Jikke Wams, PhD – Princess Maxima Center | Leontien Kremer, MD – Princess Maxima Center 

Psychosocial Challenges of Young Adult Cancer Survivors and Mitigation Strategies | 15-minute presentation | Vanessa Aguilera Snyder, PsyD — Medical College of Wisconsin

 Keys to Success for an AYA Transition | 15-minute presentation | Saro Armenian, MD – City of Hope Children’s Cancer Center 

 Panel Discussion | 15 minute 

Break | 10:30-10:45am

Focus Block 6 | 10:45-11:45am: The Art of Patient Education in Pediatric Cardio-Oncology: Partnering with Advanced Practice Providers to Optimize Cardiovascular Health 

Session Leaders: Anecita Fadol, PhD, APRN – MD Anderson Cancer Center and Molly Brickler, RN, MSN, CPNP-AC   

Introduction of the Session | 5 minute intro | Anecita Fadol, PhD, APRN – MD Anderson Cancer Center 

Challenging conversations in Pediatric Cardio-Oncology | 15-minute presentation | Molly M Brickler, RN, MSN, CPNP-AC – Children’s Wisconsin 

Monitoring for Cardiovascular Toxicities during cancer treatment | 15-minute presentation | Angela Yarbrough, DNP, APRN, FNP-BC, CPHON – MD Anderson Cancer Center  

Maintaining heart health in adult survivors of childhood cancer: Who’s responsible? | 15-minute presentation | Melissa Erickson, MD – University of Cincinnati  

Box Lunch pick up | 11:45am-12pm

Focus Block 7/Lunch Session | 12-1:30pm: Adult Survivors of Pediatric Cancer (+/- ACHD Patients) 

Session Leaders: Joseph Carver, MD – Perelman School of Medicine and Susan Dent, MD – Duke Cancer Center 

Case: Long Term Survivors of Hodgkin’s with Multiple Late Effects | Case: Adult Congenital Heart Disease Survivor with New Acute Myeloid Leukemia (AML) | Case presentations | Michael Fradley, MD – Perelman School of Medicine | Anecita Fadol, PhD, APRN – MD Anderson Cancer Center | Anne Blaes, MD – University of Minnesota  | Jonathan Menachem, MD – Vanderbilt University Medical Center 

Session (Time TBD): Fireside Chat 

Session Moderator: Steven E. Lipshultz, MD – University at Buffalo 

Eugene Herman, PhD – NCI, Toxicology and Pharmacology Branch, DTP, DCTD | Rudolf Steiner, MD – University of Zurich 

Closing Remarks | 2:30-2:40pm

Session Leaders: Steven E. Lipshultz, MD – University at Buffalo and Thomas D. Ryan, MD – Cincinnati Children’s  

 


 

Enjoy Your Stay at

The Westin, Downtown Cincinnati

The Westin overlooks historic Fountain Square and is located in the heart of central business district with fine restaurants, shops, museums, theaters, and celebrated sports stadiums close-by.

cvgwi-fountain-6187-hor-feat.jpg
 

Promotional & Exhibit Opportunities

If you are interested in promotional or exhibit opportunities at the second International Pediatric Cardio-Oncology Conference, please contact:

Ali Creaghead
513-803-1841
allison.creaghead@cchmc.org


Help Us Stay in Touch


The Second International Pediatric Cardio-Oncology Conference is jointly sponsored by Sofia’s Hope, the Cardio-Oncology Program at Cincinnati Children’s, and the Pediatric Cardiomyopathy Registry

 
CCHMC_CBI_TAG_TM_RGB_hires.jpg
 

 
 
 

The First International Pediatric Cardio-Oncology Conference is endorsed by the International Cardio-Oncology Society. IC-OS exists to advance the quality of cardio-oncology care by collaborating among educators, researchers, clinicians and allied professionals around the world.

 

Accreditation

Jointly Accredited Provider TM.jpg


In support of improving patient care, this activity has been planned and implemented by Cincinnati Children’s, Pediatric Cardiomyopathy Registry (PCMR), and Sofia’s Hope.  Cincinnati Children’s is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME: This activity has been approved for AMA PRA Category 1 Credit™. This activity is designed for the additional hours required for APRNs with prescriptive authority in Ohio.

ABP MOC Part 2: Successful completion of this CME activity enables the participant to earn MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

CNE: This activity is approved for continuing nursing education (CNE) contact hours. This activity is designed for the additional hours required for APRNs with prescriptive authority in Ohio.


IPCE_Credit_Logo_012017.jpg


This activity was planned by and for the healthcare team, and learners will receive Interprofessional Continuing Education (IPCE) credits for learning and change.


Pediatric Cardio-Oncology Webinar Series

Sponsored by Sofia's Hope and hosted by Heart University

 
 

PREVIOUS WEBINARS

Webinar 1: Updates in Pediatric Cardiology: watch now

Presenters

Steven Lipshultz, MD | Beginning with the End in Mind: Cardiotoxicity After Childhood Cancer

Thomas Ryan, MD, PhD | Cardio-Pulmonary Exercise Testing and Rehab in Cardio-Oncology

Steven Colan, MD, FACC, FASE | Differential Impact of Myocardial Mechanics in Acute Versus Late Doxorubicin Toxicity

Webinar 2: Surveillance for Cardiometabolic Disorders in Children and Adult Survivors of Childhood Cancers: watch now

Presenters

Ming Hui Chen, MD, MMSc, FACC, FASE | Case presentation

Julia Steinberger, MD, MS | Starting at the beginning - Components of metabolic syndrome and Cardiovascular risk factors in children who survived cancer

Dan Mulrooney, MD, MS | Cardiovascular Risk factors and Cardiovascular disease screening in adults who survived childhood cancers - the IGHG CAD guidelines

Elizabeth (Lieke) A. M. Feijen, PhD | Impact of alteration in anti-cancer protocols over time, on decreasing CV risk and disease 

Webinar 3: The Pharmacogenetics of Anthracycline Related Cardiomyopathy in Survivors of Pediatric Cancers: watch now

Presenters

Javier Blanco, PhD | Myocardial Determinants for the Metabolism and Toxicity of Anthracycline Drugs

Smita Bhatia, MD, MPH | The Pharmacogenetics of Anthracycline-Related Cardiomyopathy in Survivors of Pediatric Cancers

Paul Burridge, PhD | The Role of the Genome in Doxorubicin-Induced Cardiotoxicity

Greg Armstrong, MD, MSCE | Moderator